Description: ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Broomfield, Colorado.
Home Page: www.arcabio.com
ABIO Technical Analysis
10170 Church Ranch Way
Westminster,
CO
80021
United States
Phone:
720 940 2200
Officers
| Name | Title |
|---|---|
| Dr. Michael R. Bristow M.D., Ph.D. | Co-Founder, Pres, CEO & Director |
| Mr. Thomas A. Keuer | Chief Operating Officer |
| Mr. Christopher D. Ozeroff | Sr. VP, Gen. Counsel & Sec. |
| Mr. C. Jeffrey Dekker CPA | Chief Financial Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.769 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 1997-08-08 |
| Fiscal Year End: | December |
| Full Time Employees: | 17 |